-
US researchers develop CAR T cell therapy for cancer
pharmaceutical-technology
September 27, 2019
Researchers at the City of Hope cancer research centre are developing a chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed blood cancers.
-
Prostate Cancer Risk Higher in Men Receiving Fertility Treatment
drugs
September 27, 2019
Men fathering children through assisted reproduction techniques rather than natural conception have an increased risk for prostate cancer, including early-onset disease, according to a study published online in The BMJ.
-
Researchers use three-drug combination to treat lung cancer
pharmaceutical-technology
September 26, 2019
A study by the Francis Crick Institute and The Institute of Cancer Research, London has tested the combination of a G12C KRAS inhibitor with mTOR and IGF1R inhibitors for the treatment of lung cancer.
-
Leukemia drug shows promise for treating a childhood brain cancer
worldpharmanews
September 25, 2019
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor ...
-
Study finds onion and garlic consumption may reduce breast cancer risk
worldpharmanews
September 24, 2019
Onions and garlic are key ingredients in sofrito, a condiment that's a staple of Puerto Rican cuisine. They may also be a recipe for reducing the risk of breast cancer.
-
ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients
drugs
September 24, 2019
Nonsteroidal anti-inflammatory drugs (NSAIDs) are correlated with better overall survival in patients with head and neck squamous cell carcinoma (HNSCC) ...
-
Higher Mortality Seen for Male Breast Cancer Patients
drugs
September 24, 2019
Male breast cancer patients have higher mortality after cancer diagnosis than female patients, according to a study published online Sept. 19 in JAMA Oncology.
-
Can Aspirin Help Tackle Some Cancers?
drugs
September 24, 2019
Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest.
-
Colorectal Cancer Mortality Disparities Vary Across U.S. Cities
drugs
September 23, 2019
There is considerable variability in colorectal cancer (CRC) mortality disparities across urban cities...
-
New cancer drugs approvals underpinned by flawed evidence
europeanpharmaceuticalreview
September 20, 2019
A new report has shown that trial evidence alone is not enough when approving new cancer drugs and that an assessment of that evidence is also needed.